γ/total fibrinogen ratio is associated with short-term outcome in ischaemic stroke

Thrombosis and Haemostasis

Volumn 105, Issue 3, 2011, Pages 430-434

  Van Den Herik, Evita G ^a   Cheung, Elim Y L ^a   De Lau, Lonneke M L ^a   Den Hertog, Heleen M ^a   Leebeek, Frank W ^a   Dippel, Diederik W J ^a   Koudstaal, Peter J ^a   De Maat, Moniek P M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Fibrinogen '; Ischaemic stroke; Outcome

Indexed keywords

FIBRINOGEN; FIBRINOGEN GAMMA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BRAIN ISCHEMIA; CONTROLLED STUDY; FEMALE; FIBRINOGEN BLOOD LEVEL; FIBRINOGEN GAMMA TOTAL FIBRINOGEN RATIO; HEMATOLOGICAL PARAMETERS; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RANKIN SCALE;

AGED; FEMALE; FIBRINOGEN; FIBRINOGENS, ABNORMAL; HUMANS; ISCHEMIA; MALE; MIDDLE AGED; ODDS RATIO; PROGNOSIS; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; RISK FACTORS; STROKE; TREATMENT OUTCOME;

EID: 79952507952     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH10-09-0569     Document Type: Article

References (24)

1. Cheung EY, Vos HL, Kruip MJ, et al. Elevated fibrinogen gamma' ratio is associated with cardiovascular diseases and acute phase reaction but not with clinical outcome. Blood 2009; 114: 4603-4604.
2. Wolfenstein-Todel C, Mosesson MW. Human plasma fibrinogen heterogeneity: evidence for an extended carboxyl-terminal sequence in a normal gamma chain variant (gamma'). Proc Natl Acad Sci USA 1980; 77: 5069-5073. (Pubitemid 11195509)
3. Wolfenstein-Todel C, Mosesson MW. Carboxy-terminal amino acid sequence of a human fibrinogen gamma-chain variant (gamma'). Biochemistry 1981; 20: 6146-6149. (Pubitemid 12217934)
4. Chung DW, Davie EW. Gamma and gamma' chains of human fibrinogen are produced by alternative mRNA processing. Biochemistry 1984; 23: 4232-4236. (Pubitemid 14042050)
5. Mosesson MW. Antithrombin I. Inhibition of thrombin generation in plasma by fibrin formation. Thromb Haemost 2003; 89: 9-12. (Pubitemid 36149786)
6. Moaddel M, Farrell DH, Daugherty MA, et al. Interactions of human fibrinogens with factor XIII: roles of calcium and the gamma' peptide. Biochemistry 2000; 39: 6698-6705. (Pubitemid 30354002)
7. Mosesson MW. Fibrinogen and fibrin structure and functions. J Thromb Haemost 2005; 3: 1894-1904. (Pubitemid 41716577)
8. Cheung EY, Uitte de Willige S, Vos HL, et al. Fibrinogen gamma' in ischemic stroke: a case-control study. Stroke 2008; 39: 1033-1035. (Pubitemid 351619556)
9. Uitte de Willige S, de Visser MC, Houwing-Duistermaat JJ, et al. Genetic variation in the fibrinogen gamma gene increases the risk for deep venous thrombosis by reducing plasma fibrinogen gamma' levels. Blood 2005; 106: 4176-4183. (Pubitemid 41775924)
10. Lovely RS, Falls LA, Al-Mondhiry HA, et al. Association of gammaA/gamma' fibrinogen levels and coronary artery disease. Thromb Haemost 2002; 88: 26-31. (Pubitemid 34752262)
11. Mannila MN, Lovely RS, Kazmierczak SC, et al. Elevated plasma fibrinogen gamma' concentration is associated with myocardial infarction: effects of variation in fibrinogen genes and environmental factors. J Thromb Haemost 2007; 5: 766-773. (Pubitemid 46563576)
12. Nowak-Gottl U, Weiler H, Hernandez I, et al. Fibrinogen alpha and gamma genes and factor VLeiden in children with thromboembolism: results from 2 family-based association studies. Blood 2009; 114: 1947-1953.
13. Clauss A. Rapid physiological coagulation method in determination of fibrinogen. Acta Haematol 1957; 17: 237-246.
14. Adams HP, Jr., Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993; 24: 35-41.
15. van Swieten JC, Koudstaal PJ, Visser MC, et al. Interobserver agreement for the assessment of handicap in stroke patients. Stroke 1988; 19: 604-607.
16. Dziedzic T. Clinical significance of acute phase reaction in stroke patients. Front Biosci 2008; 13: 2922-2927. (Pubitemid 351589209)
17. Uitte de Willige S, Standeven KF, Philippou H, et al. The pleiotropic role of the fibrinogen gamma' chain in hemostasis. Blood 2009; 114: 3994-4001.
18. Gersh KC, Nagaswami C, Weisel JW, Lord ST. The presence of gamma' chain impairs fibrin polymerization. Thromb Res 2009; 124: 356-363.
19. Cooper AV, Standeven KF, Ariens RA. Fibrinogen gamma-chain splice variant gamma' alters fibrin formation and structure. Blood 2003; 102: 535-540. (Pubitemid 36841972)
20. Siebenlist KR, Mosesson MW, Hernandez I, et al. Studies on the basis for the properties of fibrin produced from fibrinogen-containing gamma' chains. Blood 2005; 106: 2730-2736. (Pubitemid 41510747)
21. Falls LA, Farrell DH. Resistance of gammaA/gamma' fibrin clots to fibrinolysis. J Biol Chem 1997; 272: 14251-1426.
22. Wilhelmsen L, Svardsudd K, Korsan-Bengtsen K, et al. Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med 1984; 311: 501-505. (Pubitemid 14059351)
23. Kofoed SC, Wittrup HH, Sillesen H, et al. Fibrinogen predicts ischaemic stroke and advanced atherosclerosis but not echolucent, rupture-prone carotid plaques: the Copenhagen City Heart Study. Eur Heart J 2003; 24: 567-576. (Pubitemid 36343103)
24. Danesh J, Collins R, Appleby P, et al. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. J Am Med Assoc 1998; 279: 1477-1482. (Pubitemid 28228207)